A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
NCT00424047
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
351
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
CC-5013 plus dexamethasone
DRUG:
Dexamethasone plus Placebo
Sponsor
Celgene